Skip to main content
. 2016 Aug 3;53(3):753–771. doi: 10.3233/JAD-160165

Fig.1.

Fig.1

EMF treatment, begun in young adulthood, protects AD mice (Tg) mice from cognitive impairment and improves basic memory of normal mice. Cognitive interference testing at 4-5 months (A) and 6-7 months (B) into EMF treatment revealed overall [Tg and non-Tg(NT) animals combined] cognitive benefits at the initial test point and cognitive protection of Tg mice at the later test point during the first of two test Blocks. C) Proactive interference testing during Block 2 revealed both overall benefit (at 4-5 M) and cognitive protection of Tg mice (at 6-7M). *p < 0.05 versus other group(s) at same time point; p < 0.05 versus Tg/EMF group. D) Normal (NT) mice at 6-7 months into EMF treatment showed superior Y-maze spontaneous alternation. *p < 0.05 versus all other groups.